RUTLEDGE CANCER FOUNDATION
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$1,184,283
Cash & Equivalents
51%
Investments
41%
Inventories
7%
Property, Plant, & Equipment (net)
<1%
Prepaid Expenses
<1%
Other Assets
<1%
Receivables (Non-Related)
0%
Related-Party Receivables
0%
Liabilities in 2024 (Year End)
$11,590
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$416,234
$609,041
+46%
Receivables (Non-Related)
-
-
-
Related-Party Receivables
-
-
-
Inventories
$26,968
$85,088
+216%
Prepaid Expenses
-
$2,852
-
Investments
$458,116
$482,821
+5%
Property, Plant, & Equipment (net)
$2,244
$3,081
+37%
Other Assets
$1,400
$1,400
+0%
Total Assets
$904,962
$1,184,283
+31%
Liabilities
2023
2024
Change
Payables & Accruals
$17,858
$11,590
-35%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$17,858
$11,590
-35%
Net assets
2023
2024
Change
Restricted Net Assets
$24,500
-
-
Unrestricted Net Assets
$862,604
$1,172,693
+36%
Net assets
2023
2024
Change
Net assets
+$887,104
+$1,172,693
+32%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)